GlassScriptPhysician profile
Kaitlyn Egan
NPI 1710475488
$4,110.40
in general payments reported to CMS, 2019-2025
9 companies · $629 in 2025
The $629 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $3,337 · 2024: $145 · 2025: $629.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,247 · Food and Beverage: $1,863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,247.48 |
| Food and Beverage | $1,862.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,324.20 | 2023-2025 | Proclaim |
| Boston Scientific Corporation | $591.71 | 2023 | Superion Indirect Decompression System |
| Saluda Medical Americas, INC. | $336.19 | 2023-2024 | Evoke Scs, Evoke |
| Spr Therapeutics, INC | $228.67 | 2023-2025 | Sprint Pns System |
| Stratus Medical, LLC | $180.94 | 2025 | Nimbus |
| Medtronic, INC. | $178.15 | 2023-2024 | Intellis Adaptivestim, Synchromedii |
| Abbvie INC. | $102.27 | 2023 | Botox |
| Si-Bone, INC. | $87.69 | 2025 | |
| Nalu Medical, INC. | $80.58 | 2025 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaitlyn Egan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.